Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1963 1
1964 2
1965 2
1966 3
1967 3
1969 2
1970 3
1972 1
1974 2
1976 1
1977 3
1978 2
1980 4
1981 3
1982 7
1983 3
1984 6
1985 6
1986 9
1987 5
1988 4
1989 8
1990 8
1991 19
1992 8
1993 15
1994 5
1995 19
1996 15
1997 12
1998 13
1999 12
2000 12
2001 14
2002 16
2003 28
2004 17
2005 22
2006 23
2007 21
2008 30
2009 30
2010 34
2011 36
2012 33
2013 50
2014 56
2015 53
2016 37
2017 59
2018 48
2019 51
2020 59
2021 65
2022 54
2023 52
2024 55
2025 42

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,086 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Chang YH, Hajek J, Symeonides SN, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Gurney H, Chevreau C, Melichar B, Kopyltsov E, Alva A, Burke JM, Doshi G, Topart D, Oudard S, Hammers H, Kitamura H, Bedke J, Perini RF, Zhang P, Imai K, Willemann-Rogerio J, Quinn DI, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. Among authors: quinn di. N Engl J Med. 2021 Aug 19;385(8):683-694. doi: 10.1056/NEJMoa2106391. N Engl J Med. 2021. PMID: 34407342 Free article. Clinical Trial.
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Powles T, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Gurney H, Chang YH, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Burgents JE, Xu L, Imai K, Quinn DI, Choueiri TK; KEYNOTE-564 Investigators. Powles T, et al. Among authors: quinn di. Lancet Oncol. 2022 Sep;23(9):1133-1144. doi: 10.1016/S1470-2045(22)00487-9. Lancet Oncol. 2022. PMID: 36055304 Free article. Clinical Trial.
EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma.
Rosenberg J, Sridhar SS, Zhang J, Smith D, Ruether D, Flaig TW, Baranda J, Lang J, Plimack ER, Sangha R, Heath EI, Merchan J, Quinn DI, Srinivas S, Milowsky M, Wu C, Gartner EM, Zuo P, Melhem-Bertrandt A, Petrylak DP. Rosenberg J, et al. Among authors: quinn di. J Clin Oncol. 2020 Apr 1;38(10):1041-1049. doi: 10.1200/JCO.19.02044. Epub 2020 Feb 7. J Clin Oncol. 2020. PMID: 32031899 Free PMC article. Clinical Trial.
Neurorehabilitation through a Neuropsychiatric Lens.
Peters ME, Gurin LJ, Quinn DK, Roy D. Peters ME, et al. Among authors: quinn dk. NeuroRehabilitation. 2023;53(2):173-176. doi: 10.3233/NRE-236003. NeuroRehabilitation. 2023. PMID: 37638458 No abstract available.
An electrocardiogram-based AI algorithm for early detection of pulmonary hypertension.
DuBrock HM, Wagner TE, Carlson K, Carpenter CL, Awasthi S, Attia ZI, Frantz RP, Friedman PA, Kapa S, Annis J, Brittain EL, Hemnes AR, Asirvatham SJ, Babu M, Prasad A, Yoo U, Barve R, Selej M, Agron P, Kogan E, Quinn D, Dunnmon P, Khan N, Soundararajan V. DuBrock HM, et al. Among authors: quinn d. Eur Respir J. 2024 Jul 25;64(1):2400192. doi: 10.1183/13993003.00192-2024. Print 2024 Jul. Eur Respir J. 2024. PMID: 38936966 Free PMC article.
Reply by Authors.
Mitra AP, Cai J, Miranda G, Bhanvadia S, Quinn DI, Schuckman AK, Djaladat H, Daneshmand S. Mitra AP, et al. Among authors: quinn di. J Urol. 2022 Feb;207(2):313. doi: 10.1097/JU.0000000000002242.02. Epub 2021 Nov 8. J Urol. 2022. PMID: 34994654 No abstract available.
Gastroenterology.
Quinn DN, Pfeil SA. Quinn DN, et al. Clin Podiatr Med Surg. 2002 Jan;19(1):23-42. doi: 10.1016/S0891-8422(03)00079-X. Clin Podiatr Med Surg. 2002. PMID: 11806164 Review.
Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
Goldkorn A, Tangen C, Plets M, Bsteh D, Xu T, Pinski JK, Ingles S, Triche TJ, MacVicar GR, Vaena DA, Crispino AW, McConkey DJ, Lara PN Jr, Hussain MHA, Quinn DI, Dorff TB, Lerner SP, Thompson I Jr, Agarwal N. Goldkorn A, et al. Among authors: quinn di. JAMA Netw Open. 2024 Oct 1;7(10):e2437871. doi: 10.1001/jamanetworkopen.2024.37871. JAMA Netw Open. 2024. PMID: 39374015 Free PMC article. Clinical Trial.
Editorial Comment.
D'Souza AA, Quinn DI. D'Souza AA, et al. Among authors: quinn di. J Urol. 2020 Feb;203(2):336-337. doi: 10.1097/01.JU.0000612372.02047.48. Epub 2019 Oct 29. J Urol. 2020. PMID: 31661381 No abstract available.
1,086 results